MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Investor.regeneron.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Investor.regeneron.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Investor.regeneron.com most likely does not offer any adult content.
Popular pages
-
Financial Information | Regeneron Pharmaceuticals Inc.
The Investor Relations website contains information about Regeneron Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.
-
Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results | Regeneron
TARRYTOWN, N.Y. , Feb. 4, 2022 /PRNewswire/ -- Fourth quarter 2021 revenues increased 104% to $4.95 billion versus fourth quarter 2020 including $2.30 billion attributable to REGEN-COV ® (2) ; revenue...
-
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results | Regeneron
Fourth quarter 2022 revenues decreased 31% to $3.41 billion versus fourth quarter 2021; excluding REGEN -COV ® and Ronapreve TM (a)(b) , revenues increased 14% Full year 2022 revenues decreased 24...
-
Regeneron Reports Second Quarter 2023 Financial and Operating Results | Regeneron Pharmaceuticals
Second quarter 2023 revenues increased 11% to $3.16 billion versus second quarter 2022 Second quarter 2023 Dupixent ® global net sales (recorded by Sanofi) increased 33% to $2.79 billion versus seco...
-
Regeneron Reports First Quarter 2023 Financial and Operating Results | Regeneron Pharmaceuticals Inc
First quarter 2023 revenues increased 7% to $3.16 billion versus first quarter 2022 First quarter 2023 Dupixent ® global net sales (recorded by Sanofi) increased 37% to $2 .49 billion versus first q...
-
Regeneron Reports First Quarter 2022 Financial and Operating Results | Regeneron Pharmaceuticals Inc
TARRYTOWN, N.Y. , May 4, 2022 /PRNewswire/ -- First quarter 2022 revenues increased 17% to $2.97 billion versus first quarter 2021; excluding REGEN -COV ® (a)(b) , revenues increased 25% First quarter...